Company profile for Insmed

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. The Company is dedicated to developing and bringing to market therapies that make a real difference in patients’ lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. Headquartered in Bridgewater, NJ, we are a rapidly growing com...
Insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. The Company is dedicated to developing and bringing to market therapies that make a real difference in patients’ lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. Headquartered in Bridgewater, NJ, we are a rapidly growing company with offices in seven countries.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
700 US 206, Bridgewater Township, New Jersey 08807, US
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

PEGS Boston Summit

PEGS Boston Summit

Not Confirmed

envelop Contact Supplier

PEGS Boston Summit

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/insmed-to-present-data-across-its-respiratory-portfolio-including-late-breaking-arikayce-results-from-phase-3b-encore-study-at-the-american-thoracic-society-international-conference-2026-302760845.html

PR NEWSWIRE
04 May 2026

https://www.prnewswire.com/news-releases/insmed-to-present-at-may-2026-investor-conferences-302754966.html

PR NEWSWIRE
30 Apr 2026

https://www.prnewswire.com/news-releases/insmed-to-host-first-quarter-2026-financial-results-conference-call-on-thursday-may-7-2026-302750941.html

PR NEWSWIRE
23 Apr 2026

https://www.prnewswire.com/news-releases/insmed-provides-clinical-update-on-phase-2b-cedar-study-302736190.html

PR NEWSWIRE
07 Apr 2026

https://www.fiercepharma.com/pharma/trial-results-set-insmeds-arikayce-significant-label-expansion

FIERCE PHARMA
23 Mar 2026

https://www.prnewswire.com/news-releases/insmed-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302704468.html

PR NEWSWIRE
05 Mar 2026

FDA Orange Book

read-more
read-more

Europe

read-more
read-more

01

Brand Name : Arikayce Liposomal

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : Arikayce Liposomal

arrow
PEGS Boston Summit
Not Confirmed

Insmed

Dosage Form : Nebuliser Dispersion

Dosage Strength : 590mg

Packaging :

Brand Name : Arikayce Liposomal

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

02

Brand Name : Arikayce Liposomal

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : Arikayce Liposomal

arrow
PEGS Boston Summit
Not Confirmed

Insmed

Dosage Form : Inhalation Liquid For Nebulize...

Dosage Strength : 590mg

Packaging :

Brand Name : Arikayce Liposomal

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

03

Brand Name : Arikayce Liposomal

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : Arikayce Liposomal

arrow
PEGS Boston Summit
Not Confirmed

Insmed

Dosage Form : Inhalation Liquid For Nebulize...

Dosage Strength : 590mg

Packaging :

Brand Name : Arikayce Liposomal

Approval Date : 27-10-2020

Application Number : 28106305819

Regulatory Info : Prescription

Registration Country : Denmark

blank

04

Brand Name : Arikayce Liposomal

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : Arikayce Liposomal

arrow
PEGS Boston Summit
Not Confirmed

Insmed

Dosage Form : Dispersion For Nebulizer

Dosage Strength : 590mg

Packaging :

Brand Name : Arikayce Liposomal

Approval Date : 27-10-2020

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

05

Brand Name : Brinsupri

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : Brinsupri

arrow
PEGS Boston Summit
Not Confirmed

Insmed

Dosage Form : Film Coated Tablet

Dosage Strength : 25mg

Packaging :

Brand Name : Brinsupri

Approval Date : 18-11-2025

Application Number : 2.03E+13

Regulatory Info : Approved

Registration Country : Sweden

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty